Announcements
Sidley Represents Sapiom in US$35 Million Series A Financing
August 5, 2026
Sidley represented Sapiom, Inc. in its US$35 million Series A financing round, bringing the company’s total funding to US$50 million. The round was led by Dragonfly Capital Partners, LLC, with participation from Accel, Gradient Ventures, Coinbase Ventures, Operator Collective Management, L.L.C., Formus Capital, and VanEck Ventures.
The Sidley team was led by Dr. Idan Netser and Graeme Waller (Emerging Companies and Venture Capital), and included Sara Zokaei and Alexandra Gonzalez (Emerging Companies and Venture Capital); and Jen Fernandez, James Mendenhall, and Lloyd Lyall (Global Arbitration, Trade and Advocacy).
Contacts
Capabilities
Suggested News & Insights
Recharge & Recaffeinate With Sidley @ JPMMonday, January 11, 2027 – Tuesday, January 12, 2027Sidley Represents Bolt Biotherapeutics in the Acquisition of Prana Therapies and Concurrent US$120 Million Private Placement FinancingOctober 26, 2026Sidley Represents ZAP Surgical as It Secures US$36 Million in FinancingOctober 22, 2026Sidley Represents Aquestive Therapeutics in Exclusive U.S. Licensing Agreement With Eton PharmaceuticalsOctober 16, 2026Sidley Represents Nous Research in US$90 Million Series B FinancingOctober 12, 2026Sidley Represents GE HealthCare in Its US$945 Million Acquisition of SOFIE BiosciencesOctober 7, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory




